Recent headlines from the sources AlphaScala monitors. AlphaScala analysis is published in the main market section.
Freehold Royalties shareholders approved executive compensation with 95.54% support, signaling governance alignment and removing an overhang for royalty stocks.
Japan's first land-backed digital security offers 3.4% yield on a ¥8.6B ground lease under AEON Omiya, with a $647 minimum buy-in. The 50-year term ends in 2076, leaving terminal value unresolved.
Management described a U.S. business reset as stable, removing a key overhang. The next catalyst is the follow-up on margin guidance and debt reduction.
The full Q1 2026 call transcript for Birchtech Corp. is now the primary document for assessing cash burn, revenue visibility, and the path to breakeven. The Q&A will set the stock's direction until the next filing.
Parliamentary Standards Commissioner Daniel Greenberg opened a formal probe into Nigel Farage over an undeclared £5M payment, seven weeks before the UK enacts a crypto donation ban. The inquiry could trigger a by-election in Clacton and test the post-Rycroft enforcement framework.
The 0.3 percentage point acceleration in April's M2+CD money supply adds to evidence of durable reflation, though Tokyo CPI remains the next critical test for yen traders.
Mitrade's ebook frames the problem: policy shocks now travel faster and hit more assets at once. Which correlations hold when the next shock lands?
Lulu’s Fashion Lounge (LVLU) projects positive adjusted EBITDA for 2026 with a lean $2.0M-$2.5M capex plan, shifting the narrative from survival to free cash flow breakeven.
Lulu's Fashion Lounge released its Q1 2026 earnings call transcript. The market now parses management commentary for revenue trends, margin pressure, and cash runway.
Kestra Medical Technologies' consistent post-IPO execution, highlighted at BofA's healthcare conference, lowers the perceived risk premium for other newly public device companies. The read-through extends to wearable cardiac peers.
LinkedIn is trimming paid media spend and reallocating resources to AI tools, per an internal memo. The move signals margin discipline and a bet that AI can offset paid acquisition.
Ross Stores faces a high bar after consistent outperformance. With an Alpha Score of 62 and a fair valuation, the Q1 report is the next concrete test for the off-price retailer.
T-Mobile US dismissed Deutsche Telekom combination speculation at the MoffettNathanson conference, leaving the governance question unanswered. TMUS Alpha Score 37 reflects a mixed setup. The next trigger: an 8-K filing on a special committee.
Trump's China trip during the Iran war flips the USD/CNY script. Oil repricing means the communiqué will determine whether yuan rallies or dollar demand returns.
The Proactive One2One presentation reinforces Kenmare’s shift to product-level production targets, setting up the next quarterly update as a key test for the OTC-traded stock.
Emrosi growth and PBM/GPO access gains underpin the outlook. The next catalyst is the pace of sales-force expansion and its impact on prescription volumes.
Cytosorbents' Q1 call set operating cash flow breakeven for 2H 2026 and a DrugSorb-ATR de novo submission in late 2026/early 2027. The DOAC removal market offers upside if the FDA clears the device.
Henry Schein reaffirmed its 2026 outlook and a $125M net run-rate target, backed by Q1 dental and tech growth and mid-single-digit medical ex-flu. Q2 report tests cost-save plan.
Cytosorbents' Q1 2026 earnings call on May 13 will reveal financials and pipeline updates that could swing CTSO shares. Key risk: cash runway and regulatory milestones.
The Q1 2026 presentation for Orla Mining resets the investment case for a single-asset gold producer. Camino Rojo's cost run-rate and Cerro Quema's permitting timeline are the two numbers that matter most.
Ginkgo Bioworks released Q1 2026 earnings deck, first operational update in months. Foundry revenue, cash burn, and guidance now set the stock’s direction.
Lucky Strike’s Q3 slide deck is out but contains no financial figures, leaving LUCK’s direction to the call. The real risk event is the release of actual revenue and margin numbers.
UWM Holdings' Q1 2026 slide deck provides origination volume, gain-on-sale margin, and MSR data. The earnings call Q&A and 10-Q filing are the next catalysts for UWMC.
The Q1 2026 earnings call presentation is the first detailed update on Turtle Beach's performance. Post-call analyst revisions now become the next trigger for the stock.
The slide deck provides the first detailed look at segment performance after a year of restructuring. Investors will scrutinize carbon black margins and utility pole backlog.
RICS house price balance dropped to -34 in April, well below consensus. Markets now price two to three BoE rate hikes, fueling stagflation fears. Next catalyst: BoE commentary and UK inflation print.
Anthropic CFO says AI writes 90% of code, shifting white-collar roles. The disclosure raises margin questions for software firms.
UK RICS Housing Price Balance at -34% in April, far below the -25% forecast, signals accelerating price declines. The next BoE rate decision hinge is the upcoming CPI print.
When a process fails, the creator is the last to see it. That pattern hits traders hardest. Here's how to stress-test convictions before the market does. AlphaScala desk note.
A 25-member UAE delegation including Mubadala and ADIA discussed South Korean participation in the Stargate AI data center campus, with follow-up investment projects now targeted.